The limited immunomodulatory effects of escharectomy on the kinetics of endotoxin, cytokines, and adhesion molecules in major burns.
Escharectomy has been shown to improve the survival rates and the outcomes in burns. This observational study was conducted to assess the role of escharectomy on the inflammatory mediators in major burns. Seventeen ASA physical status II or status III adult surviving major burn patients were recruited. When the escharectomy was scheduled, a series of blood samples was obtained at -3 and -1 days preoperation, and +1 and +3 postoperation. The changing levels of endotoxin, cytokines, and adhesion molecules were measured with a quantitative sandwich immunoassay. Extensive escharectomy did not appear to have any significant impact on the levels of tumor necrosis factor alpha, interleukin-10, soluble intracellular adhesion molecule-1 and soluble vascular adhesion molecule-1. Meanwhile, endotoxin and E-selectin were significantly decreased after escharectomy. Escharectomy appeared to have a limited immunomodulatory effect on the inflammatory mediators in systemic inflammatory responses induced by major burns. This is probably related to the timing and extent of surgery, and the complex nature of burn-related inflammation.
Han
Tae-Hyung
TH
Department of Anesthesiology and Pain Medicine, Hangang Sacred Heart Hospital Hallym University, College of Medicine, Seoul, Korea. athan@unitel.co.kr
Lee
Soo-Yeon
SY
Kwon
Jung-Eun
JE
Kwak
In-Suk
IS
Kim
Kwang-Min
KM
D000328:Adult; D002056:Burns / Q000276:immunology / Q000378:metabolism / Q000503:physiopathology* / Q000601:surgery*; D015815:Cell Adhesion Molecules / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D003646:Debridement; D004731:Endotoxins / Q000378:metabolism; D005260:Female; D006801:Humans; D007107:Immune System / Q000503:physiopathology*; D018836:Inflammation Mediators / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D015815:Cell Adhesion Molecules; D016207:Cytokines; D004731:Endotoxins; D018836:Inflammation Mediators